MagicMed Industries

MagicMed Industries is a drug discovery and development platform focused on next-generation psychedelic molecular compounds and derivatives. MagicMed's molecular derivative library, Psybrary™, aims to become a crucial foundation for industry partners to develop new patented products. Mission MagicMed focuses on the discovery and early development of novel drug candidates that are structurally related to classical psychedelics but possess significantly improved drug properties and commercial potential. As researchers seek to create alternative treatment solutions for a growing patient population, interest in psychedelics has re-emerged. Early clinical results, increasing support from companies and media, and the regulatory thawing of these Schedule I compounds have created a perfect framework for the industry to capitalize on the benefits offered by psychedelics. In recent years, classical psychedelics have shown potential to provide improved alternative treatment solutions for a range of mental health indications, from treatment-resistant depression and anxiety to PTSD.